McKesson to buy US Oncology for $2.16 billion, including debt
McKesson Corp. said Monday that it has agreed to buy US Oncology, a portfolio company of Welsh Carson, for about $2.16 billion, including debt.
McKesson Corporation, a leading healthcare services and information technology company, today announced that it has completed its acquisition of US Oncology, a leading integrated oncology company that serves one of the nation's largest networks of community-based oncologists.